Answer
Ipratropium bromide monohydrate in Ipravent CFC-Free Inhaler is contraindicated in patients with known hypersensitivity to atropine or its derivatives, ipratropium bromide, or any excipient listed in section 6.1.
Sources for this answer
- Ipravent CFC-Free Inhaler 20 micrograms per actuation pressurised inhalation, solution - PLGB 36390/0342Cipla EU Ltd · emc · SmPC §4.3 Contraindications · Version 4Document updated
Sources checked